BOLT Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 28.40%

Insider Buying (Last 12 Months): $11,233.22

Insider Selling (Last 12 Months): $125,191.15

Bolt Biotherapeutics Insider Trading History Chart

Bolt Biotherapeutics Share Price & Price History

^$1.11

▼ -0.04 (-3.48%)

As of 04/17/2024 01:00 AM ET

Days: 30 | 90 | 365

The A.I. story nobody is telling you (Read ASAP)

From TradeSmith | Ad

There's been a lot of buzz surrounding A.I. over the past year... Most of it is just hype and speculation. But there's one recent A.I. development you NEED to hear about...

Click here to see Louis' new video for yourself.

Bolt Biotherapeutics Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
12/12/2023	William P. Quinn	CFO	Buy	7,500	$0.95	$7,125.00	36,272
12/6/2023	William P. Quinn	CFO	Buy	2,500	$0.78	$1,950.00	28,772
11/29/2023	Edgar Engleman	Director	Sell	25,805	$0.91	$23,482.55	266,456
11/20/2023	Edgar Engleman	Director	Sell	31,257	$0.92	$28,756.44	269,823
11/20/2023	Vivo Capital Viii, Llc	Major Shareholder	Sell	54,700	$0.92	$50,324.00	113,119
11/16/2023	Edgar Engleman	Director	Sell	8,571	$0.96	$8,228.16	274,749
11/16/2023	Vivo Capital Viii, Llc	Major Shareholder	Sell	15,000	$0.96	$14,400.00	143,571
6/6/2023	William P. Quinn	CFO	Buy	1,829	$1.18	$2,158.22	26,272
7/13/2022	Holdings A/S Novo	Major Shareholder	Sell	800,000	$2.00	$1,600,000.00	3,703,991
12/8/2021	William P. Quinn	CFO	Buy	5,000	$4.71	$23,550.00
12/6/2021	William P. Quinn	CFO	Buy	35	$4.64	$162.40
6/4/2021	William P. Quinn	CFO	Buy	1,221	$16.65	$20,329.65

The A.I. story nobody is telling you (Read ASAP)

From TradeSmith | Ad

There's been a lot of buzz surrounding A.I. over the past year... Most of it is just hype and speculation. But there's one recent A.I. development you NEED to hear about...

Click here to see Louis' new video for yourself.

SEC Filings (Institutional Ownership Changes) for Bolt Biotherapeutics (NASDAQ:BOLT)

86.70% of Bolt Biotherapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Bolt Biotherapeutics Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
2/15/2024	Newtyn Management LLC	1,553,535	$1.74M	0.3%	+52.3%	4.091%
2/15/2024	Board of Trustees of The Leland Stanford Junior University	719,546	$0.81M	0.1%	-5.0%	1.895%
2/15/2024	Citadel Advisors LLC	2,458,958	$2.75M	0.0%	-13.8%	6.476%
2/13/2024	Northern Trust Corp	41,005	$46K	0.0%	+31.5%	0.108%
2/7/2024	Vivo Capital LLC	3,521,291	$3.94M	0.3%	-9.0%	9.274%
11/14/2023	Newtyn Management LLC	1,020,000	$1.06M	0.3%	+2.0%	2.688%
8/15/2023	Citadel Advisors LLC	2,986,147	$3.82M	0.0%	+5.2%	7.869%
8/11/2023	Renaissance Technologies LLC	483,939	$0.62M	0.0%	+6.0%	1.275%
8/11/2023	BlackRock Inc.	287,891	$0.37M	0.0%	+4.9%	0.759%
8/11/2023	Geode Capital Management LLC	352,219	$0.45M	0.0%	+97.9%	0.928%
8/11/2023	JPMorgan Chase & Co.	128,646	$0.17M	0.0%	-32.0%	0.339%
7/26/2023	Privium Fund Management B.V.	116,516	$0.15M	0.0%	N/A	0.308%
7/25/2023	Assenagon Asset Management S.A.	158,289	$0.20M	0.0%	-29.9%	0.419%
5/18/2023	JPMorgan Chase & Co.	189,306	$0.26M	0.0%	+850.9%	0.501%
5/16/2023	Geode Capital Management LLC	177,992	$0.25M	0.0%	+15.5%	0.471%
5/12/2023	Renaissance Technologies LLC	456,739	$0.64M	0.0%	+3.4%	1.208%
5/12/2023	Charles Schwab Investment Management Inc.	24,712	$34K	0.0%	N/A	0.065%
5/8/2023	Bailard Inc.	28,500	$40K	0.0%	N/A	0.075%
2/15/2023	Tang Capital Management LLC	400,000	$0.52M	0.1%	+100.0%	1.062%
2/15/2023	Millennium Management LLC	243,401	$0.32M	0.0%	+105.6%	0.646%
2/15/2023	Morgan Stanley	34,883	$45K	0.0%	-50.9%	0.093%
2/14/2023	Susquehanna International Group LLP	20,307	$26K	0.0%	N/A	0.054%
2/13/2023	Renaissance Technologies LLC	441,539	$0.57M	0.0%	+12.1%	1.172%
2/13/2023	Geode Capital Management LLC	154,076	$0.20M	0.0%	+8.3%	0.409%
2/13/2023	JPMorgan Chase & Co.	19,908	$26K	0.0%	+742.1%	0.053%
2/8/2023	Russell Investments Group Ltd.	40,195	$52K	0.0%	-38.2%	0.107%
1/12/2023	Assenagon Asset Management S.A.	225,816	$0.29M	0.0%	-19.3%	0.600%
1/12/2023	Marquette Asset Management LLC	97,835	$0.13M	0.0%	+53.4%	0.260%
11/15/2022	Vanguard Group Inc.	940,269	$1.39M	0.0%	+5.7%	2.497%
11/15/2022	Caas Capital Management LP	116,777	$0.17M	0.0%	N/A	0.310%
11/14/2022	Renaissance Technologies LLC	393,858	$0.58M	0.0%	-26.9%	1.046%
11/14/2022	RA Capital Management L.P.	533,432	$0.79M	0.0%	+18.5%	1.417%
11/14/2022	Ergoteles LLC	88,174	$0.13M	0.0%	-16.5%	0.234%
11/10/2022	Tower Research Capital LLC TRC	18,537	$28K	0.0%	+130.4%	0.049%
11/4/2022	Russell Investments Group Ltd.	64,995	$96K	0.0%	-32.4%	0.173%
11/1/2022	Privium Fund Management UK Ltd	116,516	$0.17M	0.2%	N/A	0.310%
10/18/2022	Bailard Inc.	46,383	$69K	0.0%	N/A	0.123%
8/18/2022	Goldman Sachs Group Inc.	33,761	$69K	0.0%	-27.0%	0.090%
8/16/2022	Prudential Financial Inc.	16,200	$33K	0.0%	N/A	0.043%
8/15/2022	Occudo Quantitative Strategies LP	30,816	$63K	0.0%	+19.5%	0.082%
8/15/2022	State Street Corp	48,737	$99K	0.0%	-84.7%	0.130%
8/15/2022	Cubist Systematic Strategies LLC	14,612	$30K	0.0%	N/A	0.039%
8/15/2022	Millennium Management LLC	191,856	$0.39M	0.0%	N/A	0.512%
8/13/2022	Renaissance Technologies LLC	538,573	$1.10M	0.0%	+85.7%	1.437%
8/12/2022	Northern Trust Corp	21,372	$44K	0.0%	-88.5%	0.057%
7/29/2022	Russell Investments Group Ltd.	96,100	$0.20M	0.0%	N/A	0.256%
7/27/2022	Assenagon Asset Management S.A.	275,552	$0.56M	0.0%	N/A	0.735%
7/15/2022	Marquette Asset Management LLC	63,779	$0.13M	0.0%	N/A	0.170%
6/7/2022	Bank of America Corp DE	10,791	$29K	0.0%	-81.7%	0.029%
5/17/2022	Eventide Asset Management LLC	859,826	$2.36M	0.0%	-40.7%	2.295%
5/16/2022	Goldman Sachs Group Inc.	46,275	$0.13M	0.0%	-90.4%	0.123%
5/16/2022	PDT Partners LLC	12,219	$33K	0.0%	N/A	0.033%
5/16/2022	Echo Street Capital Management LLC	123,804	$5.49M	0.0%	N/A	0.330%
5/13/2022	Renaissance Technologies LLC	290,100	$0.80M	0.0%	+226.3%	0.774%
5/13/2022	Northern Trust Corp	186,184	$0.51M	0.0%	-4.5%	0.497%
5/13/2022	Vanguard Group Inc.	847,810	$2.32M	0.0%	-15.1%	2.263%
5/12/2022	BlackRock Inc.	1,612,389	$4.42M	0.0%	-2.2%	4.303%
5/11/2022	Bank of New York Mellon Corp	91,293	$0.25M	0.0%	+13.0%	0.244%
5/11/2022	GSA Capital Partners LLP	54,038	$0.15M	0.0%	N/A	0.144%
5/9/2022	Qube Research & Technologies Ltd	19,611	$54K	0.0%	-57.0%	0.052%
2/19/2022	Woodline Partners LP	403,357	$1.98M	0.0%	+2.3%	1.082%
2/14/2022	Suvretta Capital Management LLC	2,230,250	$10.93M	0.2%	+68.3%	5.982%
2/14/2022	Eventide Asset Management LLC	1,449,494	$7.10M	0.1%	+171.4%	3.888%
2/11/2022	Ensign Peak Advisors Inc	18,500	$91K	0.0%	-36.0%	0.050%
2/10/2022	Qube Research & Technologies Ltd	45,640	$0.22M	0.0%	+204.2%	0.122%
2/8/2022	ProShare Advisors LLC	10,249	$50K	0.0%	N/A	0.027%
2/8/2022	Northern Trust Corp	194,893	$0.96M	0.0%	+4.3%	0.523%
2/7/2022	SG Americas Securities LLC	10,490	$51K	0.0%	-25.5%	0.028%
2/2/2022	New York State Common Retirement Fund	10,388	$51K	0.0%	+129.5%	0.028%
2/1/2022	Qube Research & Technologies Ltd	45,640	$0.22M	0.0%	+204.2%	0.122%
11/16/2021	Suvretta Capital Management LLC	1,325,500	$16.77M	0.3%	+38.9%	3.555%
11/16/2021	Metropolitan Life Insurance Co NY	7,197	$91K	0.0%	N/A	0.019%
11/16/2021	Citadel Advisors LLC	2,879,713	$36.43M	0.0%	-2.7%	7.724%
11/15/2021	Point72 Asset Management L.P.	93,960	$1.19M	0.0%	N/A	0.252%
11/15/2021	Point72 Hong Kong Ltd	2,094	$26K	0.0%	N/A	0.006%
11/15/2021	California State Teachers Retirement System	23,230	$0.29M	0.0%	+45.6%	0.062%
11/15/2021	Rock Springs Capital Management LP	1,649,248	$20.86M	0.4%	+1.9%	4.423%
11/15/2021	Sectoral Asset Management Inc	115,925	$1.47M	0.1%	-54.7%	0.311%
11/15/2021	Ensign Peak Advisors Inc	28,909	$0.37M	0.0%	+189.1%	0.078%
11/12/2021	Renaissance Technologies LLC	79,300	$1M	0.0%	+31.1%	0.213%
11/12/2021	The Manufacturers Life Insurance Company	11,017	$0.14M	0.0%	N/A	0.030%
11/12/2021	Geode Capital Management LLC	345,115	$4.37M	0.0%	+64.2%	0.928%
11/10/2021	Goldman Sachs Group Inc.	442,766	$5.60M	0.0%	+0.2%	1.190%
11/10/2021	Citigroup Inc.	2,842	$36K	0.0%	+262.0%	0.008%
11/9/2021	BlackRock Inc.	1,454,527	$18.40M	0.0%	+54.4%	3.910%
11/4/2021	Deutsche Bank AG	19,362	$0.24M	0.0%	+181.1%	0.052%
11/3/2021	Dupont Capital Management Corp	26,748	$0.34M	0.0%	N/A	0.072%
11/2/2021	New York State Common Retirement Fund	4,526	$57K	0.0%	-60.7%	0.012%
11/1/2021	SG Americas Securities LLC	14,079	$0.18M	0.0%	N/A	0.038%
9/22/2021	Nan Fung Group Holdings Ltd	1,166,952	$18.04M	5.6%	N/A	3.137%
8/17/2021	Woodline Partners LP	381,673	$5.90M	0.1%	+2.0%	1.050%
8/17/2021	Prudential Financial Inc.	20,090	$0.31M	0.0%	N/A	0.055%
8/17/2021	Citadel Advisors LLC	2,960,154	$44.86M	0.0%	+1.3%	8.146%
8/16/2021	California State Teachers Retirement System	15,960	$0.25M	0.0%	-16.6%	0.044%
8/16/2021	Morgan Stanley	276,334	$4.27M	0.0%	+5,729.8%	0.760%
8/16/2021	Maven Securities LTD	25,184	$0.39M	0.0%	N/A	0.069%
8/16/2021	Charles Schwab Investment Management Inc.	76,880	$1.19M	0.0%	-4.9%	0.212%
8/16/2021	State Street Corp	209,388	$3.24M	0.0%	+21.1%	0.576%
8/16/2021	Nuveen Asset Management LLC	53,942	$0.83M	0.0%	+16.7%	0.148%
8/16/2021	Goldman Sachs Group Inc.	441,728	$6.83M	0.0%	+93.3%	1.216%

Data available starting January 2016

Bolt Biotherapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development of immunotherapies for the treatment of cancer. The company's lead product candidate BDC-1001, which is in clinical development for the treatment of patients with human epidermal growth factor receptor 2- positive solid tumors, including breast, colorectal, endometrial, and gastroesophageal cancer. It is also developing BDC-3042, an agonist antibody targeting Dectin-2 for range of tumors, such as head and neck, non-small cell lung, ovarian, triple-negative breast, and other cancer. The company has collaboration agreements with Toray Industries, Genmab A/S, Innovent Biologics, Inc., Bristol-Myers Squibb, and F. Hoffmann-La Roche Ltd; and license agreement with Stanford University. The company was formerly known as Bolt Therapeutics, Inc. and changed its name to Bolt Biotherapeutics, Inc. in July 2015. Bolt Biotherapeutics, Inc. was incorporated in 2015 and is headquartered in Redwood City, California.

Today's Range

Now: $1.11

$1.11

$1.15

50 Day Range

MA: $1.21

$1.06

$1.50

52 Week Range

Now: $1.11

$0.84

$2.03

Volume

74,481 shs

Average Volume

136,652 shs

Market Capitalization

$42.32 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.99

Who are the company insiders with the largest holdings of Bolt Biotherapeutics?: Bolt Biotherapeutics' top insider investors include:
Holdings A/S Novo (Major Shareholder)
Edgar Engleman (Director)
Vivo Capital Viii, Llc (Major Shareholder)
William P Quinn (CFO)
Learn More about top insider investors at Bolt Biotherapeutics.